Director Scott Derrickson is all set to return to helm the sequel to his smash-hit Marvel Studios film "Doctor Strange".
According to The Hollywood Reporter, the 52-year-old director has quietly finalised a deal with Marvel for the film's sequel.
"Sherlock" star Benedict Cumberbatch had portrayed the eponymous superhero in Derrickson's 2016 film. The actor later reprised the role in Marvel Cinematic Universe's "Thor: Ragnarok" and "Avengers: Infinity War".
Cumberbatch is expected to return for the sequel to the original.
The story follows a talented neurosurgeon, Dr Stephen Strange, who, after a tragic car accident, must put ego aside and learn the secrets of a hidden world of mysticism and alternate dimensions.
Actors Rachel McAdams and Benedict Wong, who played surgeon Christine Palmer and Master Wong respectively in the first part, are also expected to be back for the sequel.
The studio also has started searching for a writer to pen the sequel. Derrickson had co-written the original with C. Robert Cargill and Jon Spaihts.
"Doctor Strange", which also featured Chiwetel Ejiofor, Mads Mikkelsen, and Tilda Swinton, had grossed over USD 670 million worldwide.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
